Cancer drug shortage causes patients, FDA to scramble for supply of 'chemotherapy backbone'

  • 📰 ABC7
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A shortage of the generic cancer drugs cisplatin and carboplatin, known as the 'chemotherapy backbone,' has experts sounding the alarm, as some patients already struggling to get life-saving care.

A shortage of the generic cancer drugs cisplatin and carboplatin, known as the "chemotherapy backbone," has experts sounding the alarm, as some patients already struggling to get life-saving care.with drug manufacturers like the Chinese drugmaker Qilu Pharmaceutical to import the cancer medication cisplatin, as well as carboplatin, to boost supply amid an ongoing shortage.

Cisplatin and other platinum-based drugs are prescribed for 10% to 20% of all cancer patients, according to the. Cisplatin has a cure rate of over 90% when used to treat testicular cancer. It also treats bladder, cervical, ovarian, lung, gastric, breast, and head and neck cancers. At a hearing last month on the shortages, lawmakers criticized the FDA for falling behind on inspections, especially of international facilities. But FDA Commissioner Dr. Robert Califf said that the agency is doing what it can even though the economic issues underlying shortages are not in its purview.

"In these situations, we very carefully assess product quality and require companies to take certain measures to ensure the products are safe for patients. The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 67. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortageShortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.
Source: CNBC - 🏆 12. / 72 Read more »

FDA says over a dozen cancer treatment drugs are under shortageA long list of cancer treatment drugs are in short supply, prompting doctors to make difficult decisions about how they treat their patients.
Source: 10News - 🏆 732. / 50 Read more »

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortageThe FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.
Source: CNBC - 🏆 12. / 72 Read more »

FDA to allow imports of cancer drug from China amid ongoing shortage | CNNThe US Food and Drug Administration is working with Chinese drugmaker Qilu Pharmaceutical to import the cancer medication cisplatin to boost supply amid an ongoing shortage.
Source: CNN - 🏆 4. / 95 Read more »